In diploid and polyploid organisms, chromosomes exist in homologous pairs. Traditional genome sequencing methods typically collapse these homologous chromosomes into a single pseudo-haploid consensus sequence. This consensus view hides the critical differences between the maternal and paternal alleles, a limitation that hampers our understanding of genetic inheritance, allele-specific expression, and complex structural variation.
Haplotype-resolved phased sequencing overcomes this limitation by separating maternal and paternal genetic information. By utilizing long-read sequencing technologies (such as PacBio HiFi and Oxford Nanopore) in combination with chromosome conformation capture (Hi-C), researchers can construct complete, chromosome-level phased assemblies. This provides an accurate blueprint of the genome, enabling precise identification of structural variants, compound heterozygosity, and regulatory elements.
"Without phasing, we are only looking at half of the genomic story. Phased genomes allow scientists to determine which mutations lie on the same chromosome (cis) versus opposite chromosomes (trans), which is fundamental for human disease genetics, plant breeding, and evolutionary biology."
Istanbul, bridging Europe and Asia, has rapidly transformed into a major hub for biotechnology, clinical diagnostics, and academic research in the Middle East and Southeastern Europe. Supported by institutions like Istanbul University, Istanbul Technical University (İTÜ), Sabancı University, and Koç University, local researchers are driving innovation in personalized medicine, rare disease research, and agricultural biotechnology.
Genomics companies and service providers in Istanbul are increasingly adopting state-of-the-art third-generation sequencing tools. With the Turkish government's focus on building a robust domestic bio-economy through TÜBİTAK (Scientific and Technological Research Council of Turkey) funding, researchers are seeking cost-effective, high-throughput solutions for phased genome sequencing. Haplotype-resolved genomes are particularly valued in Turkey due to the country's unique demographic history, which presents a high prevalence of rare genetic disorders that benefit immensely from precise allele phasing.
| Application Field | Local Application in Turkey | Key Sequencing Technology Used |
|---|---|---|
| Rare Disease Diagnostics | Phasing compound heterozygous mutations in consanguineous families. | PacBio HiFi, Oxford Nanopore, 10X Genomics |
| Agricultural Breeding | De novo sequencing of local crops (e.g., hazelnut, fig, pistachio, olive). | PacBio HiFi + Hi-C Chromatin Interaction |
| Cancer Genomics | Detecting somatic structural variants and allele-specific expression. | Long-read RNA-Seq, Metagenomics, Spatial Transcriptomics |
| Marine Metagenomics | Analyzing biodiversity in the Bosphorus and Marmara Sea. | 16S/18S/ITS Amplicon Sequencing, Shotgun Metagenomics |
The cost of haplotype-resolved sequencing has dropped significantly over the past decade, transitioning from a multi-million-dollar endeavor to an accessible research tool. In Istanbul, pricing is typically determined by the complexity of the genome (size, ploidy level, heterozygosity) and the chosen sequencing depth. A standard phased genome assembly project integrates PacBio HiFi reads (typically 30x coverage) with Hi-C data to scaffold the contigs into chromosome-level phased structures.
For researchers budgeting projects in Turkey, local service providers often work in partnership with global leaders like Biomarker Technologies (BMKGene) to leverage high-throughput sequencing facilities. This collaborative approach lowers the cost per gigabase, making advanced spatial transcriptomics, single-cell genomics, and phased de novo assemblies highly competitive. Below is an indicative overview of pricing structures commonly seen in the Istanbul biotechnology market:
| Service Type | Technical Specifications | Target Species / Focus | Estimated Market Price Range (USD) |
|---|---|---|---|
| Standard De Novo Genome | Short-read NGS (Illumina/BGI) + basic scaffolding | Microorganisms, simple fungi | $1,500 - $3,000 per genome |
| Haplotype-Resolved Phased Genome | PacBio HiFi (30x) + Hi-C Chromatin Capture | Plants, animals, complex diploid genomes | $8,000 - $15,000 per genome |
| High-Ploidy Phased Assembly | Ultra-deep Nanopore/PacBio + Hi-C + Bioinformatic Phasing | Polyploid crops (wheat, potato, etc.) | Contact for Custom Quote |
| Amplicon Sequencing (PacBio) | Full-length 16S/18S/ITS Amplicon Sequencing | Microbiome, soil/stool metagenomics | $80 - $150 per sample |
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Over 20,000 square feet facility equipped with advanced biomolecular laboratory instruments.
Standardized laboratories for sample extraction, library construction, clean rooms, and high-throughput sequencing.
Strict standard operating procedures (SOPs) applied from sample extraction to final sequencing phases.
BMKCloud Platform: Our self-developed, reliable, and easy-to-use online bioinformatics analysis platform.
Equipped with CPUs featuring 41,104 memory capacity and 3 PB total storage.
4,260 computing cores delivering peak computing power over 121,708.8 Gflop per second.
Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services worldwide, including researchers in Istanbul and across Turkey.
Quality and compliance are at the heart of BMKGene's operations. Our laboratories hold international certifications and have established joint laboratories with leading global sequencing manufacturers, ensuring that all data generated meets the highest scientific standards required by top-tier journals.
Our commitment to R&D has yielded multiple patents in genomic mapping, BSA-based marker discovery, and advanced bioinformatics algorithms. Below are some of our registered intellectual properties:
For inquiries about our products, bioinformatics services, or to request a customized quote for your projects in Istanbul or globally, please get in touch with our expert team. We will respond within 24 hours.
Inquiry Now